Rocket


Overview
Financials
News + Filings

 
 

Monte Rosa Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-20Dec-31-19
Revenues24.07.4
            Revenue growth226.6% 
Cost of goods sold28.08.0
Gross profit-4.0-0.6
            Gross margin-16.7%-8.8%
General and administrative4.00.6
EBIT-28.0-8.0
            EBIT margin-116.7%-108.8%
Pre-tax income-35.9-7.7
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-35.9-7.7
            Net margin-149.5%-105.3%
 
Diluted EPS($6.70)($1.55)
Shares outstanding (diluted)5.45.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy